A large epidemiological study of more than 600,000 veterans with diabetes suggests GLP-1 weight-loss medications may reduce ...

New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.

The massively popular drugs known as GLP-1 agonists could even halve people's risk of dying from a range of harmful substances, according to the research published in the BMJ journal.

Evidence continues to mount suggesting that GLP-1 drugs like Ozempic and Wegovy may help people cut back on cigarettes, ...

Evidence is mounting that the wildly popular weight-loss medicines known as GLP-1s may also hold potential for treating addiction, and the field may be on the verge of obtaining desperately needed ...

People taking GLP-1 drugs often talk about “food noise” vanishing: the constant mental chatter about food that dominated thei ...

Al-Aly and his colleagues found that people starting the GLP-1 drugs had lower risks of developing addiction to multiple substances. Compared with the other medications, people taking the GLP-1 drugs ...

Terri Arndt, 41, battled an eight-year addiction to huffing household cleaner 24/7, along with heroin, fentanyl and meth. After losing her home, car and children, she went cold turkey and is now two ...

Trump administration says it wants to tackle the "addiction epidemic." But it's eliminating addiction treatment resources and access to mental healthcare.

A class of medications best known for treating diabetes and obesity may also reduce the risk of addiction – and help people who already have one, a new study shows. Semaglutide (also known as Ozempic) ...

Addiction is an umbrella term that reflects qualities of substance use disorder, characterized by an inability to stop using a substance despite harmful consequences. However, addiction is not a ...

Earlier this month, a video of Alexa went viral where she detailed the horrors of living on the streets of Los Angeles.